The Prostate Cancer Foundation (PCF) will convene leading researchers, clinicians and industry experts at its 33rd Annual Scientific Retreat, October 2–4, 2026, in Carlsbad, California. The Retreat is ...
For more than a decade, patients facing certain types of prostate cancer have been able to turn to Xtandi, the now-brand name of enzalutamide, a compound breakthrough developed in the lab of Michael ...
NCI Researcher Presents Research on the Role of White Blood Cells in Bone Metastatic Prostate Cancer
The Georgetown University Lombardi Comprehensive Cancer Center held a lecture on how certain white blood cells in the immune system can contribute to bone metastatic prostate cancer as part of their ...
À l’occasion de Movember, le mois de sensibilisation aux cancers masculins, à Cholet (Maine-et-Loire), la polyclinique du ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results